- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Payer Needs and Strategies for Evaluating and Covering PDTs
Panelists delve into the data and the cost-saving evidence required by payers to cover prescription digital therapeutics (PDTs), outline the decision-making process followed by payers, and share best practices observed in real-world to ensure the successful implementation of PDTs.
EP: 1.Differentiating PDTs from Wellness Apps and Evaluating Efficacy
EP: 2.Payer Needs and Strategies for Evaluating and Covering PDTs
EP: 3.Payers Review Process and Effective Strategies for PDT Coverage
EP: 4.Stakeholder Involvement and Evidence Requirements for PDT Coverage Decisions
EP: 5.Dawn of the Age of Adopting PDTs
EP: 6.Identifying the Most Impactful Disease Areas and Patient Populations for PDTs
EP: 7.Evolving Commercialization and Distribution Models for PDTs
EP: 8.Promoting Appropriate PDT Prescribing Through Provider Education and Support
EP: 9.Optimizing Provider Education, Utilization Monitoring, and Value-Based Contracts for PDTs
EP: 10.Optimizing Benefit Design and Implementation for Improved PDT Access
EP: 11.PDTs' Role in Addressing Health Care Disparities and Priorities for Improving PDT Access
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
